Advanced Search (OLGA)

Gene: ARHGAP19 (Rho GTPase activating protein 19) Homo sapiens

Subscribe to Updates

Analyze

Symbol:

ARHGAP19

Name:

Rho GTPase activating protein 19

RGD ID:

1351019

HGNC Page

HGNC:23724

Description:

Predicted to enable GTPase activator activity. Predicted to be involved in regulation of small GTPase mediated signal transduction. Located in intracellular membrane-bounded organelle and plasma membrane.

Type:

protein-coding

RefSeq Status:

VALIDATED

Previously known as:

DKFZp313K217; MGC138804; MGC138805; MGC14258; putative RhoGAP protein; rho GTPase-activating protein 19; rho-type GTPase-activating protein 19

RGD Orthologs

Alliance Orthologs

More Info

more info ...

Allele / Splice:

See ClinVar data

Latest Assembly:

GRCh38 - Human Genome Assembly GRCh38

Position:

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	10	97,222,179 - 97,292,637 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	10	97,222,173 - 97,292,673 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	10	98,981,936 - 99,052,394 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	10	98,971,920 - 99,042,403 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	10	98,971,926 - 99,042,396	NCBI
Celera	10	92,723,490 - 92,790,901 (-)	NCBI		Celera
Cytogenetic Map	10	q24.1	NCBI
HuRef	10	92,609,973 - 92,679,489 (-)	NCBI		HuRef
CHM1_1	10	99,264,185 - 99,334,168 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	10	98,103,011 - 98,172,839 (-)	NCBI		T2T-CHM13v2.0

JBrowse:

View Region in Genome Browser (JBrowse)

Model

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ARHGAP19	Human	1-naphthyl isothiocyanate	increases expression	ISO	RGD:1593044	6480464	1-Naphthylisothiocyanate results in increased expression of ARHGAP19 mRNA	CTD	PMID:30723492
ARHGAP19	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	EXP		6480464	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP19 mRNA	CTD	PMID:20106945\|PMID:21632981
ARHGAP19	Human	2,3,7,8-tetrachlorodibenzodioxine	decreases expression	ISO	RGD:1593044	6480464	Tetrachlorodibenzodioxin results in decreased expression of ARHGAP19 mRNA	CTD	PMID:32109520\|PMID:33387578
ARHGAP19	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	EXP		6480464	Tetrachlorodibenzodioxin affects the expression of ARHGAP19 mRNA	CTD	PMID:22574217
ARHGAP19	Human	2,3,7,8-tetrachlorodibenzodioxine	affects expression	ISO	RGD:1617509	6480464	Tetrachlorodibenzodioxin affects the expression of ARHGAP19 mRNA	CTD	PMID:21570461
ARHGAP19	Human	4,4'-sulfonyldiphenol	decreases expression	ISO	RGD:1617509	6480464	bisphenol S results in decreased expression of ARHGAP19 mRNA	CTD	PMID:39298647
ARHGAP19	Human	4,4'-sulfonyldiphenol	multiple interactions	ISO	RGD:1593044	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
ARHGAP19	Human	acrolein	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ...	CTD	PMID:32699268
ARHGAP19	Human	Aflatoxin B2 alpha	affects methylation	EXP		6480464	aflatoxin B2 affects the methylation of ARHGAP19 intron	CTD	PMID:30157460
ARHGAP19	Human	alpha-pinene	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ...	CTD	PMID:32699268
ARHGAP19	Human	aristolochic acid A	decreases expression	EXP		6480464	aristolochic acid I results in decreased expression of ARHGAP19 mRNA	CTD	PMID:33212167
ARHGAP19	Human	arsane	affects methylation	EXP		6480464	Arsenic affects the methylation of ARHGAP19 gene	CTD	PMID:25304211
ARHGAP19	Human	arsenic atom	affects methylation	EXP		6480464	Arsenic affects the methylation of ARHGAP19 gene	CTD	PMID:25304211
ARHGAP19	Human	arsenous acid	increases response to substance	EXP		6480464	ARHGAP19 protein results in increased susceptibility to Arsenic Trioxide	CTD	PMID:20707922
ARHGAP19	Human	atrazine	increases expression	EXP		6480464	Atrazine results in increased expression of ARHGAP19 mRNA	CTD	PMID:22378314
ARHGAP19	Human	benzene	decreases expression	EXP		6480464	Benzene results in decreased expression of ARHGAP19 mRNA	CTD	PMID:21843810
ARHGAP19	Human	benzo[a]pyrene	affects methylation	EXP		6480464	Benzo(a)pyrene affects the methylation of ARHGAP19 intron	CTD	PMID:30157460
ARHGAP19	Human	benzo[e]pyrene	increases methylation	EXP		6480464	benzo(e)pyrene results in increased methylation of ARHGAP19 intron	CTD	PMID:30157460
ARHGAP19	Human	bis(2-ethylhexyl) phthalate	increases expression	ISO	RGD:1617509	6480464	Diethylhexyl Phthalate results in increased expression of ARHGAP19 mRNA	CTD	PMID:34319233
ARHGAP19	Human	bisphenol A	decreases expression	EXP		6480464	bisphenol A results in decreased expression of ARHGAP19 mRNA	CTD	PMID:29275510
ARHGAP19	Human	bisphenol A	multiple interactions	ISO	RGD:1593044	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
ARHGAP19	Human	bisphenol F	multiple interactions	ISO	RGD:1593044	6480464	[bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of more ...	CTD	PMID:36041667
ARHGAP19	Human	bromobenzene	decreases expression	ISO	RGD:1593044	6480464	bromobenzene results in decreased expression of ARHGAP19 mRNA	CTD	PMID:32479839
ARHGAP19	Human	cadmium atom	decreases expression	EXP		6480464	Cadmium results in decreased expression of ARHGAP19 mRNA	CTD	PMID:24376830
ARHGAP19	Human	cadmium atom	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP19 more ...	CTD	PMID:35301059
ARHGAP19	Human	cadmium dichloride	multiple interactions	EXP		6480464	[Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of ARHGAP19 more ...	CTD	PMID:35301059
ARHGAP19	Human	calcitriol	multiple interactions	EXP		6480464	[Testosterone co-treated with Calcitriol] results in decreased expression of ARHGAP19 mRNA	CTD	PMID:21592394
ARHGAP19	Human	calcitriol	decreases expression	EXP		6480464	Calcitriol results in decreased expression of ARHGAP19 mRNA	CTD	PMID:21592394
ARHGAP19	Human	carbamazepine	affects expression	EXP		6480464	Carbamazepine affects the expression of ARHGAP19 mRNA	CTD	PMID:25979313
ARHGAP19	Human	carbon nanotube	increases expression	ISO	RGD:1617509	6480464	Nanotubes, Carbon analog results in increased expression of ARHGAP19 mRNA	CTD	PMID:21624382
ARHGAP19	Human	CGP 52608	multiple interactions	EXP		6480464	CGP 52608 promotes the reaction [RORA protein binds to ARHGAP19 gene]	CTD	PMID:28238834
ARHGAP19	Human	chlorpyrifos	decreases expression	ISO	RGD:1617509	6480464	Chlorpyrifos results in decreased expression of ARHGAP19 mRNA	CTD	PMID:37019170
ARHGAP19	Human	cisplatin	decreases expression	ISO	RGD:1617509	6480464	Cisplatin results in decreased expression of ARHGAP19 mRNA	CTD	PMID:25270620
ARHGAP19	Human	coumestrol	increases expression	EXP		6480464	Coumestrol results in increased expression of ARHGAP19 mRNA	CTD	PMID:19167446
ARHGAP19	Human	diarsenic trioxide	increases response to substance	EXP		6480464	ARHGAP19 protein results in increased susceptibility to Arsenic Trioxide	CTD	PMID:20707922
ARHGAP19	Human	dioxygen	decreases expression	ISO	RGD:1617509	6480464	Oxygen deficiency results in decreased expression of ARHGAP19 mRNA	CTD	PMID:20880076
ARHGAP19	Human	dorsomorphin	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
ARHGAP19	Human	formaldehyde	decreases expression	EXP		6480464	Formaldehyde results in decreased expression of ARHGAP19 mRNA	CTD	PMID:23649840
ARHGAP19	Human	lipopolysaccharide	decreases expression	ISO	RGD:1617509	6480464	Lipopolysaccharides results in decreased expression of ARHGAP19 mRNA	CTD	PMID:26582142
ARHGAP19	Human	methapyrilene	increases methylation	EXP		6480464	Methapyrilene results in increased methylation of ARHGAP19 intron	CTD	PMID:30157460
ARHGAP19	Human	methyl methanesulfonate	decreases expression	EXP		6480464	Methyl Methanesulfonate results in decreased expression of ARHGAP19 mRNA	CTD	PMID:23649840
ARHGAP19	Human	mitomycin C	decreases expression	ISO	RGD:1617509	6480464	Mitomycin results in decreased expression of ARHGAP19 mRNA	CTD	PMID:25270620
ARHGAP19	Human	N-nitrosodiethylamine	increases expression	ISO	RGD:1617509	6480464	Diethylnitrosamine results in increased expression of ARHGAP19 mRNA	CTD	PMID:17942915
ARHGAP19	Human	N-nitrosodiethylamine	multiple interactions	ISO	RGD:1617509	6480464	MET protein inhibits the reaction [Diethylnitrosamine results in increased expression of ARHGAP19 mRNA]	CTD	PMID:17942915
ARHGAP19	Human	ozone	multiple interactions	EXP		6480464	[Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of more ...	CTD	PMID:32699268
ARHGAP19	Human	ozone	multiple interactions	ISO	RGD:1617509	6480464	[Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased more ...	CTD	PMID:34911549
ARHGAP19	Human	paracetamol	increases expression	EXP		6480464	Acetaminophen results in increased expression of ARHGAP19 mRNA	CTD	PMID:22230336
ARHGAP19	Human	paracetamol	decreases expression	ISO	RGD:1593044	6480464	Acetaminophen results in decreased expression of ARHGAP19 mRNA	CTD	PMID:33387578
ARHGAP19	Human	paracetamol	decreases expression	EXP		6480464	Acetaminophen results in decreased expression of ARHGAP19 mRNA	CTD	PMID:29067470
ARHGAP19	Human	phenylmercury acetate	decreases expression	EXP		6480464	Phenylmercuric Acetate results in decreased expression of ARHGAP19 mRNA	CTD	PMID:26272509
ARHGAP19	Human	phenylmercury acetate	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
ARHGAP19	Human	quercetin	decreases expression	EXP		6480464	Quercetin results in decreased expression of ARHGAP19 mRNA	CTD	PMID:21632981
ARHGAP19	Human	rotenone	decreases expression	ISO	RGD:1593044	6480464	Rotenone results in decreased expression of ARHGAP19 mRNA	CTD	PMID:28374803
ARHGAP19	Human	SB 431542	multiple interactions	EXP		6480464	[NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
ARHGAP19	Human	sunitinib	decreases expression	EXP		6480464	Sunitinib results in decreased expression of ARHGAP19 mRNA	CTD	PMID:31533062
ARHGAP19	Human	testosterone	multiple interactions	EXP		6480464	[Testosterone co-treated with Calcitriol] results in decreased expression of ARHGAP19 mRNA	CTD	PMID:21592394
ARHGAP19	Human	testosterone	decreases expression	EXP		6480464	Testosterone results in decreased expression of ARHGAP19 mRNA	CTD	PMID:21592394
ARHGAP19	Human	tetrachloroethene	increases expression	ISO	RGD:1617509	6480464	Tetrachloroethylene results in increased expression of ARHGAP19 mRNA	CTD	PMID:28973375
ARHGAP19	Human	tetrachloromethane	decreases expression	ISO	RGD:1593044	6480464	Carbon Tetrachloride results in decreased expression of ARHGAP19 mRNA	CTD	PMID:31150632
ARHGAP19	Human	thioacetamide	increases expression	ISO	RGD:1593044	6480464	Thioacetamide results in increased expression of ARHGAP19 mRNA	CTD	PMID:34492290
ARHGAP19	Human	titanium dioxide	decreases methylation	ISO	RGD:1617509	6480464	titanium dioxide results in decreased methylation of ARHGAP19 gene	CTD	PMID:35295148
ARHGAP19	Human	trichloroethene	decreases expression	ISO	RGD:1593044	6480464	Trichloroethylene results in decreased expression of ARHGAP19 mRNA	CTD	PMID:33387578
ARHGAP19	Human	trichostatin A	decreases expression	EXP		6480464	trichostatin A results in decreased expression of ARHGAP19 mRNA	CTD	PMID:26272509
ARHGAP19	Human	trichostatin A	multiple interactions	EXP		6480464	[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ...	CTD	PMID:27188386
ARHGAP19	Human	triphenyl phosphate	affects expression	EXP		6480464	triphenyl phosphate affects the expression of ARHGAP19 mRNA	CTD	PMID:37042841
ARHGAP19	Human	trovafloxacin	decreases expression	ISO	RGD:1617509	6480464	trovafloxacin results in decreased expression of ARHGAP19 mRNA	CTD	PMID:35537566
ARHGAP19	Human	valproic acid	affects expression	EXP		6480464	Valproic Acid affects the expression of ARHGAP19 mRNA	CTD	PMID:25979313
ARHGAP19	Human	valproic acid	decreases expression	EXP		6480464	Valproic Acid results in decreased expression of ARHGAP19 mRNA	CTD	PMID:23179753\|PMID:27188386
ARHGAP19	Human	zoledronic acid	decreases expression	EXP		6480464	zoledronic acid results in decreased expression of ARHGAP19 mRNA	CTD	PMID:20977926

Biological Process

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ARHGAP19	Human	regulation of small GTPase mediated signal transduction	involved_in	TAS		150520179		Reactome	Reactome:R-HSA-9012999
ARHGAP19	Human	regulation of small GTPase mediated signal transduction	involved_in	IBA	PANTHER:PTN000384138\|UniProtKB:Q8N392	150520179		GO_Central	GO_REF:0000033
ARHGAP19	Human	signal transduction	involved_in	IEA	InterPro:IPR000198	150520179		InterPro	GO_REF:0000002

Cellular Component

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ARHGAP19	Human	cytoplasm	is_active_in	IBA	FB:FBgn0039994\|PANTHER:PTN000384138\|UniProtKB:Q8N392	150520179		GO_Central	GO_REF:0000033
ARHGAP19	Human	cytosol	located_in	TAS		150520179		Reactome	Reactome:R-HSA-8981637
ARHGAP19	Human	nucleus	located_in	IEA	UniProtKB-SubCell:SL-0191	150520179		UniProt	GO_REF:0000044
ARHGAP19	Human	nucleus	located_in	IEA	UniProtKB-KW:KW-0539	150520179		UniProt	GO_REF:0000043
ARHGAP19	Human	plasma membrane	located_in	IDA		150520179		HPA	GO_REF:0000052

Molecular Function

Only show annotations with direct experimental evidence (0 objects hidden)

Object Symbol	Species	Term	Qualifier	Evidence	With	Reference	Notes	Source	Original Reference(s)
ARHGAP19	Human	GTPase activator activity	enables	IBA	FB:FBgn0039994\|MGI:1921160\|PANTHER:PTN000384138\|UniProtKB:Q8N392	150520179		GO_Central	GO_REF:0000033
ARHGAP19	Human	GTPase activator activity	enables	TAS		150520179		Reactome	Reactome:R-HSA-8981637
ARHGAP19	Human	GTPase activator activity	enables	IEA	UniProtKB-KW:KW-0343	150520179		UniProt	GO_REF:0000043
ARHGAP19	Human	protein binding	enables	IPI	UniProtKB:P54252	150520179	PMID:16713569, PMID:32814053	IntAct	PMID:16713569\|PMID:32814053

#	Reference Title	Reference Citation
1.	Data Import for Chemical-Gene Interactions	RGD automated import pipeline for gene-chemical interactions

PMID:8619474	PMID:9110174	PMID:12477932	PMID:12693554	PMID:14702039	PMID:15164054	PMID:15489334	PMID:16344560	PMID:16385451	PMID:16713569	PMID:17454002	PMID:19322201
PMID:21873635	PMID:22939629	PMID:23503679	PMID:24259668	PMID:27173435	PMID:28514442	PMID:29420299	PMID:31536960	PMID:32203420	PMID:32814053	PMID:32994395	PMID:33407571
PMID:33961781	PMID:34296808	PMID:34299191	PMID:35271311	PMID:35944360	PMID:36543142	PMID:36897256	PMID:36931259	PMID:37267103	PMID:37827155

ARHGAP19
(Homo sapiens - human)

Human Assembly	Chr	Position (strand)	Source	Genome Browsers
Human Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCh38	10	97,222,179 - 97,292,637 (-)	NCBI	GRCh38	GRCh38	hg38	GRCh38
GRCh38.p14 Ensembl	10	97,222,173 - 97,292,673 (-)	Ensembl	GRCh38		hg38	GRCh38
GRCh37	10	98,981,936 - 99,052,394 (-)	NCBI	GRCh37	GRCh37	hg19	GRCh37
Build 36	10	98,971,920 - 99,042,403 (-)	NCBI	NCBI36	Build 36	hg18	NCBI36
Build 34	10	98,971,926 - 99,042,396	NCBI
Celera	10	92,723,490 - 92,790,901 (-)	NCBI		Celera
Cytogenetic Map	10	q24.1	NCBI
HuRef	10	92,609,973 - 92,679,489 (-)	NCBI		HuRef
CHM1_1	10	99,264,185 - 99,334,168 (-)	NCBI		CHM1_1
T2T-CHM13v2.0	10	98,103,011 - 98,172,839 (-)	NCBI		T2T-CHM13v2.0

Arhgap19
(Mus musculus - house mouse)

Mouse Assembly	Chr	Position (strand)	Source	Genome Browsers
Mouse Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCm39	19	41,755,027 - 41,790,523 (-)	NCBI	GRCm39	GRCm39	mm39
GRCm39 Ensembl	19	41,755,027 - 41,790,486 (-)	Ensembl		GRCm39 Ensembl
GRCm38	19	41,766,588 - 41,802,084 (-)	NCBI	GRCm38	GRCm38	mm10	GRCm38
GRCm38.p6 Ensembl	19	41,766,588 - 41,802,047 (-)	Ensembl	GRCm38		mm10	GRCm38
MGSCv37	19	41,841,078 - 41,876,574 (-)	NCBI	GRCm37	MGSCv37	mm9	NCBIm37
MGSCv36	19	41,822,896 - 41,855,345 (-)	NCBI		MGSCv36	mm8
Celera	19	42,565,944 - 42,601,293 (-)	NCBI		Celera
Cytogenetic Map	19	C3	NCBI
cM Map	19	35.19	NCBI

Arhgap19
(Rattus norvegicus - Norway rat)

Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
GRCr8	1	250,519,703 - 250,566,705 (-)	NCBI		GRCr8
mRatBN7.2	1	240,571,554 - 240,617,361 (-)	NCBI	mRatBN7.2	mRatBN7.2
mRatBN7.2 Ensembl	1	240,580,871 - 240,617,287 (-)	Ensembl		mRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx	1	248,726,358 - 248,762,787 (-)	NCBI	Rnor_SHR	UTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.0	1	255,423,509 - 255,459,938 (-)	NCBI	Rnor_SHRSP	UTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.0	1	248,076,520 - 248,112,949 (-)	NCBI	Rnor_WKY	UTH_Rnor_WKY_Bbb_1.0
Rnor_6.0	1	261,015,083 - 261,051,515 (-)	NCBI	Rnor6.0	Rnor_6.0	rn6	Rnor6.0
Rnor_6.0 Ensembl	1	261,015,123 - 261,051,498 (-)	Ensembl	Rnor6.0		rn6	Rnor6.0
Rnor_5.0	1	268,467,998 - 268,504,196 (-)	NCBI	Rnor5.0	Rnor_5.0	rn5	Rnor5.0
Celera	1	236,417,793 - 236,454,050 (-)	NCBI		Celera
Cytogenetic Map	1	q54	NCBI

Arhgap19
(Chinchilla lanigera - long-tailed chinchilla)

Chinchilla Assembly	Chr	Position (strand)	Source	Genome Browsers
Chinchilla Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChiLan1.0 Ensembl	NW_004955507	3,403,846 - 3,471,884 (-)	Ensembl	ChiLan1.0
ChiLan1.0	NW_004955507	3,400,273 - 3,471,943 (-)	NCBI	ChiLan1.0	ChiLan1.0

ARHGAP19
(Pan paniscus - bonobo/pygmy chimpanzee)

Bonobo Assembly	Chr	Position (strand)	Source	Genome Browsers
Bonobo Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
NHGRI_mPanPan1-v2	8	109,138,192 - 109,209,490 (-)	NCBI		NHGRI_mPanPan1-v2
NHGRI_mPanPan1	10	109,143,512 - 109,214,816 (-)	NCBI		NHGRI_mPanPan1
Mhudiblu_PPA_v0	10	93,845,870 - 93,917,842 (-)	NCBI	Mhudiblu_PPA_v0	Mhudiblu_PPA_v0	panPan3
PanPan1.1	10	97,340,568 - 97,412,538 (-)	NCBI	panpan1.1	PanPan1.1	panPan2
PanPan1.1 Ensembl	10	97,340,568 - 97,412,538 (-)	Ensembl	panpan1.1		panPan2

ARHGAP19
(Canis lupus familiaris - dog)

Dog Assembly	Chr	Position (strand)	Source	Genome Browsers
Dog Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
CanFam3.1	28	10,556,278 - 10,621,032 (-)	NCBI	CanFam3.1	CanFam3.1	canFam3	CanFam3.1
Dog10K_Boxer_Tasha	28	10,739,777 - 10,803,940 (-)	NCBI		Dog10K_Boxer_Tasha
ROS_Cfam_1.0	28	10,878,208 - 10,943,056 (-)	NCBI		ROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl	28	10,878,126 - 10,942,986 (-)	Ensembl		ROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1	28	10,539,879 - 10,604,434 (-)	NCBI		UMICH_Zoey_3.1
UNSW_CanFamBas_1.0	28	10,601,086 - 10,665,164 (-)	NCBI		UNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0	28	10,741,124 - 10,805,093 (-)	NCBI		UU_Cfam_GSD_1.0

Arhgap19
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)

Squirrel Assembly	Chr	Position (strand)	Source	Genome Browsers
Squirrel Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HiC_Itri_2	NW_024407213	36,309,480 - 36,357,895 (+)	NCBI		HiC_Itri_2
SpeTri2.0 Ensembl	NW_004936636	2,348,589 - 2,398,500 (+)	Ensembl	SpeTri2.0	SpeTri2.0 Ensembl
SpeTri2.0	NW_004936636	2,348,613 - 2,394,914 (+)	NCBI	SpeTri2.0	SpeTri2.0		SpeTri2.0

ARHGAP19
(Sus scrofa - pig)

Pig Assembly	Chr	Position (strand)	Source	Genome Browsers
Pig Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
Sscrofa11.1	14	108,666,228 - 108,739,098 (-)	NCBI	Sscrofa11.1	Sscrofa11.1	susScr11	Sscrofa11.1
Sscrofa10.2	14	118,276,957 - 118,282,335 (-)	NCBI	Sscrofa10.2	Sscrofa10.2	susScr3

ARHGAP19
(Chlorocebus sabaeus - green monkey)

Green Monkey Assembly	Chr	Position (strand)	Source	Genome Browsers
Green Monkey Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
ChlSab1.1	9	90,396,061 - 90,469,716 (-)	NCBI	ChlSab1.1	ChlSab1.1	chlSab2
ChlSab1.1 Ensembl	9	90,334,674 - 90,469,609 (-)	Ensembl	ChlSab1.1	ChlSab1.1 Ensembl	chlSab2
Vero_WHO_p1.0	NW_023666048	51,288,111 - 51,364,238 (-)	NCBI	Vero_WHO_p1.0	Vero_WHO_p1.0

Arhgap19
(Heterocephalus glaber - naked mole-rat)

Naked Mole-Rat Assembly	Chr	Position (strand)	Source	Genome Browsers
Naked Mole-Rat Assembly	Chr	Position (strand)	Source	JBrowse	NCBI	UCSC	Ensembl
HetGla_female_1.0 Ensembl	NW_004624737	8,886,986 - 8,982,650 (-)	Ensembl	HetGla_female_1.0	HetGla_female_1.0 Ensembl	hetGla2
HetGla 1.0	NW_004624737	8,887,036 - 8,982,699 (-)	NCBI	HetGla_female_1.0	HetGla 1.0	hetGla2

Variants in ARHGAP19
41 total Variants

Name	Type	Condition(s)	Position(s)	Clinical significance
GRCh38/hg38 10q23.33-25.3(chr10:95112607-116776637)x3	copy number gain	See cases [RCV000050747]	Chr10:95112607..116776637 [GRCh38] Chr10:96872364..118383651 [GRCh37] Chr10:96862354..118526138 [NCBI36] Chr10:10q23.33-25.3	pathogenic
GRCh38/hg38 10q23.33-24.2(chr10:92626680-97755102)x1	copy number loss	See cases [RCV000052564]	Chr10:92626680..97755102 [GRCh38] Chr10:94386437..99514859 [GRCh37] Chr10:94376417..99504849 [NCBI36] Chr10:10q23.33-24.2	pathogenic
GRCh38/hg38 10q23.33-24.32(chr10:93181201-101356779)x1	copy number loss	See cases [RCV000052565]	Chr10:93181201..101356779 [GRCh38] Chr10:94940958..103116536 [GRCh37] Chr10:94930948..103106526 [NCBI36] Chr10:10q23.33-24.32	pathogenic
GRCh38/hg38 10q23.31-26.3(chr10:91048545-133620674)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053560]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053560]\|See cases [RCV000053560]	Chr10:91048545..133620674 [GRCh38] Chr10:92808302..135434178 [GRCh37] Chr10:92798282..135284168 [NCBI36] Chr10:10q23.31-26.3	pathogenic
GRCh38/hg38 10q24.1(chr10:96601018-97382040)x3	copy number gain	Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053561]\|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053561]\|See cases [RCV000053561]	Chr10:96601018..97382040 [GRCh38] Chr10:98360775..99141797 [GRCh37] Chr10:98350765..99131787 [NCBI36] Chr10:10q24.1	pathogenic
GRCh37/hg19 10q24.1(chr10:98941691-99153357)x3	copy number gain	See cases [RCV000240430]	Chr10:98941691..99153357 [GRCh37] Chr10:10q24.1	uncertain significance
GRCh37/hg19 10q23.1-25.1(chr10:85557432-105804295)x1	copy number loss	Poly (ADP-Ribose) polymerase inhibitor response [RCV000431909]	Chr10:85557432..105804295 [GRCh37] Chr10:10q23.1-25.1	pathogenic\|drug response
GRCh37/hg19 10p15.3-q26.3(chr10:93297-135378918)x3	copy number gain	See cases [RCV000448750]	Chr10:93297..135378918 [GRCh37] Chr10:10p15.3-q26.3	pathogenic
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)	copy number gain	See cases [RCV000511389]	Chr10:100027..135427143 [GRCh37] Chr10:10p15.3-q26.3	pathogenic\|uncertain significance
GRCh37/hg19 10p15.3-q26.3(chr10:100027-135427143)x3	copy number gain	See cases [RCV000510861]	Chr10:100027..135427143 [GRCh37] Chr10:10p15.3-q26.3	pathogenic
GRCh37/hg19 10q23.32-26.3(chr10:93283493-135427143)x3	copy number gain	See cases [RCV000510972]	Chr10:93283493..135427143 [GRCh37] Chr10:10q23.32-26.3	pathogenic
NM_032900.6(ARHGAP19):c.1421C>T (p.Thr474Met)	single nucleotide variant	not specified [RCV004314351]	Chr10:97229200 [GRCh38] Chr10:98988957 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.667C>T (p.Arg223Trp)	single nucleotide variant	not specified [RCV004301007]	Chr10:97259575 [GRCh38] Chr10:99019332 [GRCh37] Chr10:10q24.1	uncertain significance
GRCh37/hg19 10q11.21-26.3(chr10:42347406-135534747)x1	copy number loss	Poly (ADP-Ribose) polymerase inhibitor response [RCV000626438]	Chr10:42347406..135534747 [GRCh37] Chr10:10q11.21-26.3	drug response
GRCh37/hg19 10q23.32-24.2(chr10:93908171-101809723)x1	copy number loss	See cases [RCV000512315]	Chr10:93908171..101809723 [GRCh37] Chr10:10q23.32-24.2	pathogenic
GRCh37/hg19 10q23.33-26.3(chr10:94346520-135427143)x3	copy number gain	not provided [RCV000683291]	Chr10:94346520..135427143 [GRCh37] Chr10:10q23.33-26.3	pathogenic
GRCh37/hg19 10q24.1(chr10:98974462-99135215)x3	copy number gain	not provided [RCV000737280]	Chr10:98974462..99135215 [GRCh37] Chr10:10q24.1	benign
GRCh37/hg19 10q24.1(chr10:98903394-99097191)x1	copy number loss	not provided [RCV000749794]	Chr10:98903394..99097191 [GRCh37] Chr10:10q24.1	benign
GRCh37/hg19 10p15.3-q26.3(chr10:73232-135524321)x3	copy number gain	not provided [RCV000749464]	Chr10:73232..135524321 [GRCh37] Chr10:10p15.3-q26.3	pathogenic
GRCh37/hg19 10p15.3-q26.3(chr10:98087-135477883)x3	copy number gain	not provided [RCV000749465]	Chr10:98087..135477883 [GRCh37] Chr10:10p15.3-q26.3	pathogenic
GRCh37/hg19 10q24.1(chr10:98873648-99006083)x3	copy number gain	not provided [RCV000845625]	Chr10:98873648..99006083 [GRCh37] Chr10:10q24.1	uncertain significance
GRCh37/hg19 10q24.1-24.2(chr10:99027360-99300723)x1	copy number loss	not provided [RCV002472884]	Chr10:99027360..99300723 [GRCh37] Chr10:10q24.1-24.2	uncertain significance
NM_032900.6(ARHGAP19):c.28G>C (p.Glu10Gln)	single nucleotide variant	not specified [RCV004230850]	Chr10:97292600 [GRCh38] Chr10:99052357 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.719G>A (p.Arg240His)	single nucleotide variant	not specified [RCV004193317]	Chr10:97259523 [GRCh38] Chr10:99019280 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.985G>T (p.Ala329Ser)	single nucleotide variant	not specified [RCV004196680]	Chr10:97246280 [GRCh38] Chr10:99006037 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1178T>C (p.Ile393Thr)	single nucleotide variant	not specified [RCV004206700]	Chr10:97243975 [GRCh38] Chr10:99003732 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.661A>G (p.Lys221Glu)	single nucleotide variant	not specified [RCV004095131]	Chr10:97259581 [GRCh38] Chr10:99019338 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.269G>T (p.Gly90Val)	single nucleotide variant	not specified [RCV004117331]	Chr10:97265913 [GRCh38] Chr10:99025670 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1093A>G (p.Thr365Ala)	single nucleotide variant	not specified [RCV004071526]	Chr10:97244060 [GRCh38] Chr10:99003817 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.442A>G (p.Ser148Gly)	single nucleotide variant	not specified [RCV004165971]	Chr10:97263591 [GRCh38] Chr10:99023348 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.236T>C (p.Leu79Pro)	single nucleotide variant	not specified [RCV004117655]	Chr10:97265946 [GRCh38] Chr10:99025703 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.191A>G (p.Asn64Ser)	single nucleotide variant	not specified [RCV004083354]	Chr10:97265991 [GRCh38] Chr10:99025748 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1220G>T (p.Arg407Leu)	single nucleotide variant	not specified [RCV004178867]	Chr10:97235281 [GRCh38] Chr10:98995038 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.960G>C (p.Leu320Phe)	single nucleotide variant	not specified [RCV004106054]	Chr10:97246305 [GRCh38] Chr10:99006062 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.344C>T (p.Ser115Phe)	single nucleotide variant	not specified [RCV004279508]	Chr10:97264885 [GRCh38] Chr10:99024642 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.317G>A (p.Arg106Gln)	single nucleotide variant	not specified [RCV004276884]	Chr10:97265865 [GRCh38] Chr10:99025622 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1252G>A (p.Ala418Thr)	single nucleotide variant	not specified [RCV004268526]	Chr10:97235249 [GRCh38] Chr10:98995006 [GRCh37] Chr10:10q24.1	uncertain significance
GRCh37/hg19 10p13-q26.3(chr10:12829206-135427143)	copy number loss	Distal 10q deletion syndrome [RCV003319583]	Chr10:12829206..135427143 [GRCh37] Chr10:10p13-q26.3	pathogenic
GRCh37/hg19 10p14-q26.3(chr10:11138692-135427143)	copy number gain	Distal trisomy 10q [RCV003319593]	Chr10:11138692..135427143 [GRCh37] Chr10:10p14-q26.3	pathogenic
NM_032900.6(ARHGAP19):c.582T>G (p.His194Gln)	single nucleotide variant	not specified [RCV004358842]	Chr10:97263451 [GRCh38] Chr10:99023208 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.47C>G (p.Ser16Cys)	single nucleotide variant	not specified [RCV004361498]	Chr10:97292581 [GRCh38] Chr10:99052338 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1138G>A (p.Val380Ile)	single nucleotide variant	not specified [RCV004365277]	Chr10:97244015 [GRCh38] Chr10:99003772 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.961C>T (p.His321Tyr)	single nucleotide variant	not provided [RCV003422783]	Chr10:97246304 [GRCh38] Chr10:99006061 [GRCh37] Chr10:10q24.1	likely benign
GRCh37/hg19 10q11.21-24.2(chr10:42709645-100834951)x3	copy number gain	not provided [RCV003484798]	Chr10:42709645..100834951 [GRCh37] Chr10:10q11.21-24.2	pathogenic
GRCh37/hg19 10q23.31-24.2(chr10:90796994-100067505)x1	copy number loss	not specified [RCV003986861]	Chr10:90796994..100067505 [GRCh37] Chr10:10q23.31-24.2	pathogenic
GRCh37/hg19 10q23.33-26.3(chr10:95078198-135427143)x3	copy number gain	not specified [RCV003986893]	Chr10:95078198..135427143 [GRCh37] Chr10:10q23.33-26.3	pathogenic
NM_032900.6(ARHGAP19):c.29A>C (p.Glu10Ala)	single nucleotide variant	not specified [RCV004422439]	Chr10:97292599 [GRCh38] Chr10:99052356 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.143A>C (p.Lys48Thr)	single nucleotide variant	not specified [RCV004422437]	Chr10:97266039 [GRCh38] Chr10:99025796 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.472C>T (p.Leu158Phe)	single nucleotide variant	not specified [RCV004422441]	Chr10:97263561 [GRCh38] Chr10:99023318 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.922T>C (p.Phe308Leu)	single nucleotide variant	not specified [RCV004422443]	Chr10:97256323 [GRCh38] Chr10:99016080 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.386T>C (p.Ile129Thr)	single nucleotide variant	not specified [RCV004422440]	Chr10:97264843 [GRCh38] Chr10:99024600 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.546G>A (p.Met182Ile)	single nucleotide variant	not specified [RCV004422442]	Chr10:97263487 [GRCh38] Chr10:99023244 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1106C>T (p.Thr369Met)	single nucleotide variant	not specified [RCV004422436]	Chr10:97244047 [GRCh38] Chr10:99003804 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.956G>T (p.Arg319Ile)	single nucleotide variant	not specified [RCV004666775]	Chr10:97246309 [GRCh38] Chr10:99006066 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1063C>T (p.Arg355Trp)	single nucleotide variant	not specified [RCV004657749]	Chr10:97244090 [GRCh38] Chr10:99003847 [GRCh37] Chr10:10q24.1	uncertain significance
GRCh37/hg19 10q23.2-24.31(chr10:88755921-102461203)x1	copy number loss	not provided [RCV004819364]	Chr10:88755921..102461203 [GRCh37] Chr10:10q23.2-24.31	pathogenic
NM_032900.6(ARHGAP19):c.1216G>A (p.Gly406Arg)	single nucleotide variant	not specified [RCV004845212]	Chr10:97235285 [GRCh38] Chr10:98995042 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.90T>A (p.Asp30Glu)	single nucleotide variant	not specified [RCV004845223]	Chr10:97266092 [GRCh38] Chr10:99025849 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1033T>C (p.Phe345Leu)	single nucleotide variant	not specified [RCV004845232]	Chr10:97244120 [GRCh38] Chr10:99003877 [GRCh37] Chr10:10q24.1	uncertain significance
GRCh37/hg19 10q23.33-24.2(chr10:94283369-101820913)x1	copy number loss	not specified [RCV003986912]	Chr10:94283369..101820913 [GRCh37] Chr10:10q23.33-24.2	pathogenic
NM_032900.6(ARHGAP19):c.1195C>G (p.Gln399Glu)	single nucleotide variant	not specified [RCV004657755]	Chr10:97235306 [GRCh38] Chr10:98995063 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1246A>G (p.Lys416Glu)	single nucleotide variant	not specified [RCV004657768]	Chr10:97235255 [GRCh38] Chr10:98995012 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1376G>A (p.Ser459Asn)	single nucleotide variant	not specified [RCV004845208]	Chr10:97229783 [GRCh38] Chr10:98989540 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.593A>G (p.Asn198Ser)	single nucleotide variant	not specified [RCV004845206]	Chr10:97263440 [GRCh38] Chr10:99023197 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.1355T>C (p.Ile452Thr)	single nucleotide variant	not specified [RCV004845217]	Chr10:97229804 [GRCh38] Chr10:98989561 [GRCh37] Chr10:10q24.1	uncertain significance
NM_032900.6(ARHGAP19):c.565G>A (p.Glu189Lys)	single nucleotide variant	not specified [RCV004845218]	Chr10:97263468 [GRCh38] Chr10:99023225 [GRCh37] Chr10:10q24.1	uncertain significance

Predicted Target Of

	Summary Value
Count of predictions:	7887
Count of miRNA genes:	1471
Interacting mature miRNAs:	2022
Transcripts:	ENST00000316676, ENST00000355366, ENST00000358308, ENST00000358531, ENST00000371027, ENST00000453547, ENST00000466484, ENST00000487035, ENST00000492211, ENST00000493068
Prediction methods:	Microtar, Miranda, Rnahybrid, Targetscan
Result types:	miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

The following QTLs overlap with this region.

RGD ID	Symbol	Name	LOD	P Value	Trait	Sub Trait	Chr	Start	Stop	Species
597367929	GWAS1464003_H	risk-taking behaviour QTL GWAS1464003 (human)		1e-15	risk-taking behaviour		10	97238438	97238439	Human
597481370	GWAS1577444_H	neutrophil count QTL GWAS1577444 (human)		2e-67	neutrophil quantity (VT:0000222)	blood neutrophil count (CMO:0000030)	10	97241501	97241502	Human
596961372	GWAS1080891_H	metabolic syndrome QTL GWAS1080891 (human)		8e-10	metabolic syndrome		10	97265854	97265855	Human
597329747	GWAS1425821_H	neuroticism measurement, cognitive function measurement QTL GWAS1425821 (human)		8e-11	cognitive behavior trait (VT:0010450)		10	97229002	97229003	Human
597342384	GWAS1438458_H	body mass index QTL GWAS1438458 (human)		1e-08	body mass index	body mass index (BMI) (CMO:0000105)	10	97229697	97229698	Human
597060924	GWAS1156998_H	metabolic syndrome QTL GWAS1156998 (human)		8e-10	metabolic syndrome		10	97265854	97265855	Human
597290548	GWAS1386622_H	lymphocyte measurement, neutrophil measurement QTL GWAS1386622 (human)		8e-14	lymphocyte measurement, neutrophil measurement		10	97229697	97229698	Human
597466897	GWAS1562971_H	body mass index QTL GWAS1562971 (human)		2e-09	body mass index	body mass index (BMI) (CMO:0000105)	10	97241501	97241502	Human
2314551	GLUCO52_H	Glucose level QTL 52 (human)	1.4		Glucose level		10	77605006	103605006	Human
597098691	GWAS1194765_H	body mass index QTL GWAS1194765 (human)		3e-09	body mass index	body mass index (BMI) (CMO:0000105)	10	97229697	97229698	Human
597425295	GWAS1521369_H	lymphocyte:monocyte ratio QTL GWAS1521369 (human)		4e-11	leukocyte quantity (VT:0000217)		10	97248311	97248312	Human
597458984	GWAS1555058_H	neutrophil-to-lymphocyte ratio QTL GWAS1555058 (human)		5e-09	neutrophil quantity (VT:0000222)		10	97264397	97264398	Human
596956099	GWAS1075618_H	lymphocyte measurement, neutrophil measurement QTL GWAS1075618 (human)		8e-14	lymphocyte measurement, neutrophil measurement		10	97229697	97229698	Human
596986572	GWAS1106091_H	leukocyte count QTL GWAS1106091 (human)		4e-08	leukocyte count		10	97243618	97243619	Human

STS-F10974

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	10	98,982,106 - 98,982,187	UniSTS	GRCh37
Build 36	10	98,972,096 - 98,972,177	RGD	NCBI36
Celera	10	92,723,666 - 92,723,747	RGD
Cytogenetic Map	10	q24.1	UniSTS
HuRef	10	92,610,149 - 92,610,230	UniSTS
GeneMap99-GB4 RH Map	10	455.78	UniSTS

RH102738

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	10	98,983,345 - 98,983,490	UniSTS	GRCh37
Build 36	10	98,973,335 - 98,973,480	RGD	NCBI36
Celera	10	92,724,905 - 92,725,050	RGD
Cytogenetic Map	10	q24.1	UniSTS
HuRef	10	92,611,388 - 92,611,533	UniSTS
GeneMap99-GB4 RH Map	10	461.29	UniSTS

D10S2453

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	10	98,989,970 - 98,990,132	UniSTS	GRCh37
Build 36	10	98,979,960 - 98,980,122	RGD	NCBI36
Celera	10	92,731,530 - 92,731,692	RGD
HuRef	10	92,618,013 - 92,618,175	UniSTS

ARHGAP19__4358

Human Assembly	Chr	Position (strand)	Source	JBrowse
GRCh37	10	98,985,022 - 98,985,634	UniSTS	GRCh37
Build 36	10	98,975,012 - 98,975,624	RGD	NCBI36
Celera	10	92,726,582 - 92,727,194	RGD
HuRef	10	92,613,065 - 92,613,677	UniSTS

Click on a value in the shaded box below the category label to view a detailed expression data table for that system.

Download All Expressed Objects for this Gene

adipose tissue	alimentary part of gastrointestinal system	appendage	circulatory system	ectoderm	endocrine system	endoderm	entire extraembryonic component	exocrine system	hemolymphoid system	hepatobiliary system	integumental system	mesenchyme	mesoderm	musculoskeletal system	nervous system	pharyngeal arch	renal system	reproductive system	respiratory system	sensory system	visual system
1204	2439	2788	2253	4974	1726	2351	6	624	1949	465	2270	7304	6470	53	3734	1	852	1744	1617	175	1


RefSeq Transcripts	NM_001204300	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_001256423	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	NM_032900	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
GenBank Nucleotide	AA427792	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK074122	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK090447	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK093316	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK093441	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AK303055	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	AL359385	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC007848	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC082250	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC103749	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC113888	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BC114490	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BI830638	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BX648189	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	BX648194	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CD743029	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CH471066	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CP068268	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	CR749412	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DB069205	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	DQ338460	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	LS482313	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles
	U79256	(Get FASTA)	NCBI Sequence Viewer	Search GEO for Microarray Profiles

Ensembl Acc Id:

ENST00000358308 ⟹ ENSP00000351058

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,222,176 - 97,292,673 (-)	Ensembl

Ensembl Acc Id:

ENST00000358531 ⟹ ENSP00000351333

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,222,179 - 97,292,637 (-)	Ensembl

Ensembl Acc Id:

ENST00000371027 ⟹ ENSP00000360066

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,225,309 - 97,270,664 (-)	Ensembl

Ensembl Acc Id:

ENST00000466484 ⟹ ENSP00000473667

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,259,430 - 97,292,635 (-)	Ensembl

Ensembl Acc Id:

ENST00000487035

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,222,180 - 97,256,515 (-)	Ensembl

Ensembl Acc Id:

ENST00000492211 ⟹ ENSP00000473327

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,222,173 - 97,292,623 (-)	Ensembl

Ensembl Acc Id:

ENST00000493068

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38.p14 Ensembl	10	97,265,380 - 97,292,637 (-)	Ensembl

RefSeq Acc Id:

NM_001204300 ⟹ NP_001191229

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,222,179 - 97,292,637 (-)	NCBI
GRCh37	10	98,981,930 - 99,052,430 (-)	ENTREZGENE
HuRef	10	92,609,973 - 92,679,489 (-)	ENTREZGENE
CHM1_1	10	99,264,185 - 99,334,168 (-)	NCBI
T2T-CHM13v2.0	10	98,103,011 - 98,172,839 (-)	NCBI

Sequence:

show sequence

GCTGACGAAGATGGCGACTGAGGCACAGAGTGAAGGGGAGGTGCCAGCCCGCGAATCCGGCCGGAGTGATGCCATCTGCAGTTTTGTGATCTGCAATGATTCTTCCCTTCGAGGTCAGCCCATTATCT
TTAATCCTGACTTTTTTGTGGAGAAACTCCGACATGAGAAACCTGAGATTTTCACTGAGTTGGTGGTCAGCAATATCACAAGGCTCATCGATTTACCTGGAACTGAGTTGGCTCAGCTGATGGGGGAA
GTGGACCTTAAGTTGCCTGGCGGGGCTGGCCCAGCATCAGGATTCTTCCGGTCTCTCATGTCTCTCAAGCGAAAGGAAAAAGGAGTGATATTTGGGTCCCCACTGACGGAGGAAGGCATTGCCCAGAT
ATACCAACTGATTGAGTATCTACACAAAAACTTGCGAGTAGAGGGTTTGTTTAGAGTACCGGGTAATAGTGTCCGACAGCAGATTTTAAGGGATGCTCTCAATAATGGAACTGACATTGACTTGGAAT
CAGGGGAATTTCACTCAAATGATGTTGCCACTTTGCTGAAGATGTTTCTAGGAGAGTTGCCGGAGCCTCTGCTGACACATAAACACTTCAATGCACACCTCAAAATCGCTGATTTGATGCAGTTTGAT
GATAAAGGAAACAAGACCAATATACCAGACAAGGACCGGCAAATTGAGGCTCTCCAGTTGCTCTTCCTCATTCTCCCTCCTCCTAATCGTAATTTGCTGAAGTTATTGCTTGATCTCCTATACCAGAC
AGCAAAGAAACAAGACAAGAACAAGATGTCAGCCTATAACCTTGCCCTTATGTTTGCACCCCATGTCCTGTGGCCAAAAAATGCTCCTGCTTACATTCGGGAGTGTGCGAGATTGCACTATTTGGGAT
CCAGAACTCAGGCATCAAAGGATGACCTTGACCTCATAGCTTCATGTCATACTAAGTCCTTTCAGCTGGCAAAGTCTCAGAAACGGAACCGGGTAGATTCCTGCCCTCACCAGGAGGAGACCCAGCAC
CATACGGAAGAGGCACTGAGAGAGCTGTTTCAACACGTTCATGATATGCCAGAGTCAGCAAAGAAGAAACAACTTATTAGACAGTTTAATAAGCAATCATTGACCCAGACACCAGGGCGAGAACCTTC
TACTTCCCAGGTACAAAAGAGGGCTCGTTCGCGCTCCTTCAGTGGGCTTATTAAGCGGAAGGTCCTGGGAAATCAGATGATGTCAGAAAAGAAAAAGAAGAACCCTACTCCAGAATCTGTGGCCATTG
GTGAATTGAAGGGAACCAGCAAAGAAAATAGGAACTTATTATTTTCTGGCTCTCCAGCTGTCACGATGACACCAACAAGATTGAAGTGGTCTGAAGGGAAGAAAGAGGGGAAAAAAGGATTTCTCTGA
AGGATCCAGAGTTGTCTCCTATGGTCCATGCAGAATTTTCTGTTTAGTGGGCAGGTGTTATTCCTGCCCACAGCAAAGCTTGGACTTGCAGCTTGCTTGCTGCATTTTGAATTGTCAAAGCCAACTAA
TACCGTGACCCGACTGATACCTCTAACCCCACTCACTGGATGATGTTTGCAAGCTGTGCCTTCTGAGAGAGTGCTTAGGCCCTGTCTCTCTTTTTTAATATTATGGGGAAACCACTAACTATCCAACC
AGCTTATACAGCACACTAAGGTGGGCTTCAGTGCTCACTCAATGTGTTTAGGCAGATTCCACTTTTGAAAAAAAATATGAAATGTGTGCTCAACTGCCAGTAATTTTTTAAAAAGCACTGTCCCAGTG
GATTGATGTTGTTTTTAATGGATATTTTGGGTTTTTCTCTGTTTTGATAGTATTGGGTATTTGGTTGTTTTTGTTTGTTTATTTCTTTGTTTTAAAAGCCATGTTTTTGGTTGGGCTCTAAGCTAGAT
ATCTTTCCCTCTTTTTCACTTTGAGCTTTGGGAAAACTCTTTATCTTATGAGGCTGTATTCCTCAATACCTAATTTGTGTCCAAAGAATTTATAGCTTTTCTGGACATTTTTTATTATTTCTTGGGTG
TGACATCAGAGTATTTGACCTGCAGTATTGAAAAAGGAGAATTCAGAATGATACAGTATTTTAACAAATCTTAATTATTAAACTCTTTTCCTTCCTTCCATTTCTCCCTCCCTTGTCCATCTCTCTCT
CTCTTTCCCTTTCCTCAGTGATGTGAAAATAATTGTGTTTTGCTGAACTTGTTATCTTCATTCAATTTCCTCTTGACTAAAACATCTCTGGTGCCAACGTAATACTTCTGAACCAAATCACTGTGACT
CAAGGAAAGTCACTGACAGCATAAGAGAAGTTTGCTAAAATATTTGTATGTGGGGGAAGCTCTGGAGTGTGCCTAGGAGGGGGCTGGCTGCCTTTATGTCCCAGGATGACTCTTTATGGGTGGGATTA
CATTGCACCCTCTGAGGGTGCAGGCTAGACCGTCTCCTGAGAGGAAGTTAGGATCAGAAAGAAGAAGCAAGCAGCAACCTCTGCAGGGCTGACAGGATTTAAAGGAGAGAATGTTCTTATTTGGAAGC
AGCTGTGGCTTGTCACCAATGTTCAAGGAGTGTTACTGTTCCGCCCTCTCTTTGTCAGAAGGGACACAGGTGGTAATTTGGAGATGGGGCCAGAGCTTCTGGCTTTTGGATTTGGTGTGTTCACTTGT
GTTGGATAGAGCAGTGGCATGGCTTTGACCTAGTATGAACTGGTGTCTGCCCAGAGAGCAGCATGTAGCAGGGGGGAATGCTCAGGTTTGTGCCTGGCTCTGTGGAGCTGTACAACCCTTCTCACCCT
GTGGGTTGGAGCCGAGTCAGGCCACTATGGGGAAGCAGTTGCCCCACAAAATGTGGTTTGCTGACCTATTTCTAAACTGTTGAATATGCTGCACCATTGCTGAAATGAAAGATGACTCTGGGGGAGCA
GAGCTTGGCCTTGTGCCCAGCTGGCAGCCCCCTCTGCCAGCCTTTCTGCTGCTTTTGCTGCTGTAACAGCAATAGTGGAGAAAAATGTAAAATTTGGTCTTCCAGCTTAATGCAGTGTGAACAATAGA
TGGTTAGGAAAACAAAACTGCTTAGAAGCCCCTTTCTCTAGAGCAGTTTTATGTCATTTGTAAAAACACATATTAGCAAATTCGTTTGCGTAGGTTTCTATTAAATATTTGACTTTTTTTTTCTTATT
AAGAAAATGAAATCCCTTACACCAGATATCAGTTAATTCAAACAGAAAACCCTTTGGGTATCACCAAATTGAAATGGTATTCTTCCTTAACTCTTCCTTCTTTCCTTTATTTGTTTAGACGTGCTTCA
TCCCGAAGTGGTGCTATGGTCTGTTAAACAGGGCTGGCATCAGGTAGAGGGAGCAGAGTGGTGACCTGATAGCTCCTGTCATCGTGTTAGTTTTTGATTCTATTTAAGGGAAGTAGCTGAGATTTAGA
CGGATGTAGATGCTCTTTGGGTGAATGGAATCATAAGCAAAGGTTGTGTTCTGGGGTGAGGATCATGAGAGAGATATTTATCACATGCACATGCCTTTATATAGCTGGTCTCCTTGGGTGGTTTATGT
GTGTTTTGTTTATTTATTGAATATGTTTTCCCTTGCTTTAGGGGTTTTATAGGTCATTTTTCTTAATAGAAGCTGTGATCGACTTAGAATCCAAATTTGAGGAGTAAGCAGCATAACCTTCTACCTTG
TAATATGTAACTATTCTAATCCAGTGGAATCTTACGGAAAACACAGAGAAAACCCCTTTTATCATTTGCCACAGAAGGCTGCTGTCTCCCTTCTGATTTGGTGGGCAGGTATTGTTTTTGAGCCAGTA
TTTAACAGAGTTTTTTAATCTATAAGATTTTTTTTGAATCTATTTCATTGTGTTTGTTTTTCATGTTGGAACAATCTCTCTGGAAGTGCCTCTTCTTGTGGCTTTTACAACTTCATTTCTTTCTGGGG
TCACCTGTGATGGGCTTTGATGTGGTGTCAATTTGGGGCCTTGTGTTTGTGCCAGAGGGATACACATATTAAACTGCAGGCCACCTTCCTGGTCCAGACTGTACTGTGTGAACCCCACTGACTAAATT
AGTGAGAACCATAGGCGTTGGAATTTCTCACCTTTTACAATGATAGACTTTTGCATTGGGACCAATGAATCTGGTGTGAAAAACCCTGCTGTAGTAGTGAAAGAGCATCAGGAGATACTGACTGTACC
TGAGGGCCAAAACAGGAGCAGGTAACGAACCGTAAAAAAAGGAGCAGGTAATGAATCGTAACCAAAACTACAGTTGATCCTCCGCAAAGGAAAGCTCTTTACCCAGAATGTCCTTCCAGAGTCATTCA
GGAAGGACAAGGGAACACCCTTGGGAAATGGGCTAGTGGAGGGCTGTTGACTGCAGTGACACCTGGGTGCTCCGGAGGTATCTGTTCTGTTGACCTGTAAGGAAGCAGTCGATCCTAGAGTGTCAGAA
CAGAGCCATTCTCTCCTCCTGAGTAGGAACGTTTCTGTTCAGTTTCCCTCACAGCAGCCTGTGTTAGCATGCAGTTGAAAATACTGCCGTCTAGGAGAACCTGTGGTCACTGGGAACGTGCCCCACAG
TGACTGGCCATGCAACCAGGTGATTTTTAGGAATAGATGTCTCTAGACTCTGTCTCCTTTCCTACAAGGCCTCACACAGATGCTTGAGGCTAATGGCCCCCATTCTGAGGTCATTTTTGTGTAGAACT
CCTTTCCCCAGGAGAGAGCCTTATCTCTGCCCTCCTTTACCCTGAAGGCTTCAAACGGAAGACAGGACCTAGATCTAAACCTAGATACTAGCATTTTGTGGGATTGTCTAGAATTTGGGGAAGATTTG
GGTTCCTAAGATGCACAAGCGTTTTACACCAGTGGTGATTAACTCAACTAAAACCCACTGTAGGAAGTTAGCTTCCCCAGACAGCTAATGCCGAGATCTTCTACCAGCGTAGAGTTGACAGAAGCAGG
CCAGCGAGGAGGTGTGGGACATAATAGCCTGAGTGCTTGGGTTACCATGGAGACTGGAGTGTGTGAGGCCACAGCCTGTGCTAAAGAGCCATGGAGCCCTCCCCTGGCCATGTCTGGGGACAGATAGA
ACCTGTTGGGGGAAATATTCCCTCACCCCAGGGTTCTTTCTGCAGAGCAAGGGTTGCCTTTGTCCTATCCCTGAGCTTGCTCAACAAGAGAAACAAGGTTTCTTAAGTGTTTTGGTTAAAGTTTTCAT
TCTTATTTGACTATGTATATGTAATTGTAAAGAAACGATCCTATGCATTGTCTTTCTTTTATATTCTTGTAATATTCTGAAATTAAAATTGTTTTGTTTCATA

hide sequence

RefSeq Acc Id:

NM_001256423 ⟹ NP_001243352

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,222,179 - 97,270,657 (-)	NCBI
GRCh37	10	98,981,930 - 99,052,430 (-)	NCBI
HuRef	10	92,609,973 - 92,679,489 (-)	NCBI
CHM1_1	10	99,264,185 - 99,312,567 (-)	NCBI
T2T-CHM13v2.0	10	98,103,011 - 98,153,392 (-)	NCBI

Sequence:

show sequence

CTTCCTGTCTCTTCGATTTACCAATGCCTCATCAGAAACTTTCAGCACTTATTGATGCCATCTGCAGTTTTGTGATCTGCAATGATTCTTCCCTTCGAGGTCAGCCCATTATCTTTAATCCTGACTTT
TTTGTGGAGAAACTCCGACATGAGAAACCTGAGATTTTCACTGAGTTGGTGGTCAGCAATATCACAAGGCTCATCGATTTACCTGGAACTGAGTTGGCTCAGCTGATGGGGGAAGTGGACCTTAAGTT
GCCTGGCGGGGCTGGCCCAGCATCAGGATTCTTCCGGTCTCTCATGTCTCTCAAGCGAAAGGAAAAAGGAGTGATATTTGGGTCCCCACTGACGGAGGAAGGCATTGCCCAGATATACCAACTGATTG
AGTATCTACACAAAAACTTGCGAGTAGAGGGTTTGTTTAGAGTACCGGGTAATAGTGTCCGACAGCAGATTTTAAGGGATGCTCTCAATAATGGAACTGACATTGACTTGGAATCAGGGGAATTTCAC
TCAAATGATGTTGCCACTTTGCTGAAGATGTTTCTAGGAGAGTTGCCGGAGCCTCTGCTGACACATAAACACTTCAATGCACACCTCAAAATCGCTGATTTGATGCAGTTTGATGATAAAGGAAACAA
GACCAATATACCAGACAAGGACCGGCAAATTGAGGCTCTCCAGTTGCTCTTCCTCATTCTCCCTCCTCCTAATCGTAATTTGCTGAAGTTATTGCTTGATCTCCTATACCAGACAGCAAAGAAACAAG
ACAAGAACAAGATGTCAGCCTATAACCTTGCCCTTATGTTTGCACCCCATGTCCTGTGGCCAAAAAATGTCACTGCAAATGACCTTCAGGAGAATATCACAAAGTTAAACAGTGGGATGGCTTTTATG
ATTAAACACTCCCAGAAACTTTTTAAGGCTCCTGCTTACATTCGGGAGTGTGCGAGATTGCACTATTTGGGATCCAGAACTCAGGCATCAAAGGATGACCTTGACCTCATAGCTTCATGTCATACTAA
GTCCTTTCAGCTGGCAAAGTCTCAGAAACGGAACCGGGTAGATTCCTGCCCTCACCAGGAGGAGACCCAGCACCATACGGAAGAGGCACTGAGAGAGCTGTTTCAACACGTTCATGATATGCCAGAGT
CAGCAAAGAAGAAACAACTTATTAGACAGTTTAATAAGCAATCATTGACCCAGACACCAGGGCGAGAACCTTCTACTTCCCAGGTACAAAAGAGGGCTCGTTCGCGCTCCTTCAGTGGGCTTATTAAG
CGGAAGGTCCTGGGAAATCAGATGATGTCAGAAAAGAAAAAGAAGAACCCTACTCCAGAATCTGTGGCCATTGGTGAATTGAAGGGAACCAGCAAAGAAAATAGGAACTTATTATTTTCTGGCTCTCC
AGCTGTCACGATGACACCAACAAGATTGAAGTGGTCTGAAGGGAAGAAAGAGGGGAAAAAAGGATTTCTCTGAAGGATCCAGAGTTGTCTCCTATGGTCCATGCAGAATTTTCTGTTTAGTGGGCAGG
TGTTATTCCTGCCCACAGCAAAGCTTGGACTTGCAGCTTGCTTGCTGCATTTTGAATTGTCAAAGCCAACTAATACCGTGACCCGACTGATACCTCTAACCCCACTCACTGGATGATGTTTGCAAGCT
GTGCCTTCTGAGAGAGTGCTTAGGCCCTGTCTCTCTTTTTTAATATTATGGGGAAACCACTAACTATCCAACCAGCTTATACAGCACACTAAGGTGGGCTTCAGTGCTCACTCAATGTGTTTAGGCAG
ATTCCACTTTTGAAAAAAAATATGAAATGTGTGCTCAACTGCCAGTAATTTTTTAAAAAGCACTGTCCCAGTGGATTGATGTTGTTTTTAATGGATATTTTGGGTTTTTCTCTGTTTTGATAGTATTG
GGTATTTGGTTGTTTTTGTTTGTTTATTTCTTTGTTTTAAAAGCCATGTTTTTGGTTGGGCTCTAAGCTAGATATCTTTCCCTCTTTTTCACTTTGAGCTTTGGGAAAACTCTTTATCTTATGAGGCT
GTATTCCTCAATACCTAATTTGTGTCCAAAGAATTTATAGCTTTTCTGGACATTTTTTATTATTTCTTGGGTGTGACATCAGAGTATTTGACCTGCAGTATTGAAAAAGGAGAATTCAGAATGATACA
GTATTTTAACAAATCTTAATTATTAAACTCTTTTCCTTCCTTCCATTTCTCCCTCCCTTGTCCATCTCTCTCTCTCTTTCCCTTTCCTCAGTGATGTGAAAATAATTGTGTTTTGCTGAACTTGTTAT
CTTCATTCAATTTCCTCTTGACTAAAACATCTCTGGTGCCAACGTAATACTTCTGAACCAAATCACTGTGACTCAAGGAAAGTCACTGACAGCATAAGAGAAGTTTGCTAAAATATTTGTATGTGGGG
GAAGCTCTGGAGTGTGCCTAGGAGGGGGCTGGCTGCCTTTATGTCCCAGGATGACTCTTTATGGGTGGGATTACATTGCACCCTCTGAGGGTGCAGGCTAGACCGTCTCCTGAGAGGAAGTTAGGATC
AGAAAGAAGAAGCAAGCAGCAACCTCTGCAGGGCTGACAGGATTTAAAGGAGAGAATGTTCTTATTTGGAAGCAGCTGTGGCTTGTCACCAATGTTCAAGGAGTGTTACTGTTCCGCCCTCTCTTTGT
CAGAAGGGACACAGGTGGTAATTTGGAGATGGGGCCAGAGCTTCTGGCTTTTGGATTTGGTGTGTTCACTTGTGTTGGATAGAGCAGTGGCATGGCTTTGACCTAGTATGAACTGGTGTCTGCCCAGA
GAGCAGCATGTAGCAGGGGGGAATGCTCAGGTTTGTGCCTGGCTCTGTGGAGCTGTACAACCCTTCTCACCCTGTGGGTTGGAGCCGAGTCAGGCCACTATGGGGAAGCAGTTGCCCCACAAAATGTG
GTTTGCTGACCTATTTCTAAACTGTTGAATATGCTGCACCATTGCTGAAATGAAAGATGACTCTGGGGGAGCAGAGCTTGGCCTTGTGCCCAGCTGGCAGCCCCCTCTGCCAGCCTTTCTGCTGCTTT
TGCTGCTGTAACAGCAATAGTGGAGAAAAATGTAAAATTTGGTCTTCCAGCTTAATGCAGTGTGAACAATAGATGGTTAGGAAAACAAAACTGCTTAGAAGCCCCTTTCTCTAGAGCAGTTTTATGTC
ATTTGTAAAAACACATATTAGCAAATTCGTTTGCGTAGGTTTCTATTAAATATTTGACTTTTTTTTTCTTATTAAGAAAATGAAATCCCTTACACCAGATATCAGTTAATTCAAACAGAAAACCCTTT
GGGTATCACCAAATTGAAATGGTATTCTTCCTTAACTCTTCCTTCTTTCCTTTATTTGTTTAGACGTGCTTCATCCCGAAGTGGTGCTATGGTCTGTTAAACAGGGCTGGCATCAGGTAGAGGGAGCA
GAGTGGTGACCTGATAGCTCCTGTCATCGTGTTAGTTTTTGATTCTATTTAAGGGAAGTAGCTGAGATTTAGACGGATGTAGATGCTCTTTGGGTGAATGGAATCATAAGCAAAGGTTGTGTTCTGGG
GTGAGGATCATGAGAGAGATATTTATCACATGCACATGCCTTTATATAGCTGGTCTCCTTGGGTGGTTTATGTGTGTTTTGTTTATTTATTGAATATGTTTTCCCTTGCTTTAGGGGTTTTATAGGTC
ATTTTTCTTAATAGAAGCTGTGATCGACTTAGAATCCAAATTTGAGGAGTAAGCAGCATAACCTTCTACCTTGTAATATGTAACTATTCTAATCCAGTGGAATCTTACGGAAAACACAGAGAAAACCC
CTTTTATCATTTGCCACAGAAGGCTGCTGTCTCCCTTCTGATTTGGTGGGCAGGTATTGTTTTTGAGCCAGTATTTAACAGAGTTTTTTAATCTATAAGATTTTTTTTGAATCTATTTCATTGTGTTT
GTTTTTCATGTTGGAACAATCTCTCTGGAAGTGCCTCTTCTTGTGGCTTTTACAACTTCATTTCTTTCTGGGGTCACCTGTGATGGGCTTTGATGTGGTGTCAATTTGGGGCCTTGTGTTTGTGCCAG
AGGGATACACATATTAAACTGCAGGCCACCTTCCTGGTCCAGACTGTACTGTGTGAACCCCACTGACTAAATTAGTGAGAACCATAGGCGTTGGAATTTCTCACCTTTTACAATGATAGACTTTTGCA
TTGGGACCAATGAATCTGGTGTGAAAAACCCTGCTGTAGTAGTGAAAGAGCATCAGGAGATACTGACTGTACCTGAGGGCCAAAACAGGAGCAGGTAACGAACCGTAAAAAAAGGAGCAGGTAATGAA
TCGTAACCAAAACTACAGTTGATCCTCCGCAAAGGAAAGCTCTTTACCCAGAATGTCCTTCCAGAGTCATTCAGGAAGGACAAGGGAACACCCTTGGGAAATGGGCTAGTGGAGGGCTGTTGACTGCA
GTGACACCTGGGTGCTCCGGAGGTATCTGTTCTGTTGACCTGTAAGGAAGCAGTCGATCCTAGAGTGTCAGAACAGAGCCATTCTCTCCTCCTGAGTAGGAACGTTTCTGTTCAGTTTCCCTCACAGC
AGCCTGTGTTAGCATGCAGTTGAAAATACTGCCGTCTAGGAGAACCTGTGGTCACTGGGAACGTGCCCCACAGTGACTGGCCATGCAACCAGGTGATTTTTAGGAATAGATGTCTCTAGACTCTGTCT
CCTTTCCTACAAGGCCTCACACAGATGCTTGAGGCTAATGGCCCCCATTCTGAGGTCATTTTTGTGTAGAACTCCTTTCCCCAGGAGAGAGCCTTATCTCTGCCCTCCTTTACCCTGAAGGCTTCAAA
CGGAAGACAGGACCTAGATCTAAACCTAGATACTAGCATTTTGTGGGATTGTCTAGAATTTGGGGAAGATTTGGGTTCCTAAGATGCACAAGCGTTTTACACCAGTGGTGATTAACTCAACTAAAACC
CACTGTAGGAAGTTAGCTTCCCCAGACAGCTAATGCCGAGATCTTCTACCAGCGTAGAGTTGACAGAAGCAGGCCAGCGAGGAGGTGTGGGACATAATAGCCTGAGTGCTTGGGTTACCATGGAGACT
GGAGTGTGTGAGGCCACAGCCTGTGCTAAAGAGCCATGGAGCCCTCCCCTGGCCATGTCTGGGGACAGATAGAACCTGTTGGGGGAAATATTCCCTCACCCCAGGGTTCTTTCTGCAGAGCAAGGGTT
GCCTTTGTCCTATCCCTGAGCTTGCTCAACAAGAGAAACAAGGTTTCTTAAGTGTTTTGGTTAAAGTTTTCATTCTTATTTGACTATGTATATGTAATTGTAAAGAAACGATCCTATGCATTGTCTTT
CTTTTATATTCTTGTAATATTCTGAAATTAAAATTGTTTTGTTTCATA

hide sequence

RefSeq Acc Id:

NM_032900 ⟹ NP_116289

RefSeq Status:

VALIDATED

Type:

CODING

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,222,179 - 97,292,637 (-)	NCBI
GRCh37	10	98,981,930 - 99,052,430 (-)	ENTREZGENE
Build 36	10	98,971,920 - 99,042,403 (-)	NCBI Archive
Celera	10	92,723,490 - 92,790,901 (-)	RGD
HuRef	10	92,609,973 - 92,679,489 (-)	ENTREZGENE
CHM1_1	10	99,264,185 - 99,334,168 (-)	NCBI
T2T-CHM13v2.0	10	98,103,011 - 98,172,839 (-)	NCBI

Sequence:

show sequence

GCTGACGAAGATGGCGACTGAGGCACAGAGTGAAGGGGAGGTGCCAGCCCGCGAATCCGGCCGG
AGTGATGCCATCTGCAGTTTTGTGATCTGCAATGATTCTTCCCTTCGAGGTCAGCCCATTATCTTTAATCCTGACTTTTTTGTGGAGAAACTCCGACATGAGAAACCTGAGATTTTCACTGAGTTGGT
GGTCAGCAATATCACAAGGCTCATCGATTTACCTGGAACTGAGTTGGCTCAGCTGATGGGGGAAGTGGACCTTAAGTTGCCTGGCGGGGCTGGCCCAGCATCAGGATTCTTCCGGTCTCTCATGTCTC
TCAAGCGAAAGGAAAAAGGAGTGATATTTGGGTCCCCACTGACGGAGGAAGGCATTGCCCAGATATACCAACTGATTGAGTATCTACACAAAAACTTGCGAGTAGAGGGTTTGTTTAGAGTACCGGGT
AATAGTGTCCGACAGCAGATTTTAAGGGATGCTCTCAATAATGGAACTGACATTGACTTGGAATCAGGGGAATTTCACTCAAATGATGTTGCCACTTTGCTGAAGATGTTTCTAGGAGAGTTGCCGGA
GCCTCTGCTGACACATAAACACTTCAATGCACACCTCAAAATCGCTGATTTGATGCAGTTTGATGATAAAGGAAACAAGACCAATATACCAGACAAGGACCGGCAAATTGAGGCTCTCCAGTTGCTCT
TCCTCATTCTCCCTCCTCCTAATCGTAATTTGCTGAAGTTATTGCTTGATCTCCTATACCAGACAGCAAAGAAACAAGACAAGAACAAGATGTCAGCCTATAACCTTGCCCTTATGTTTGCACCCCAT
GTCCTGTGGCCAAAAAATGTCACTGCAAATGACCTTCAGGAGAATATCACAAAGTTAAACAGTGGGATGGCTTTTATGATTAAACACTCCCAGAAACTTTTTAAGGCTCCTGCTTACATTCGGGAGTG
TGCGAGATTGCACTATTTGGGATCCAGAACTCAGGCATCAAAGGATGACCTTGACCTCATAGCTTCATGTCATACTAAGTCCTTTCAGCTGGCAAAGTCTCAGAAACGGAACCGGGTAGATTCCTGCC
CTCACCAGGAGGAGACCCAGCACCATACGGAAGAGGCACTGAGAGAGCTGTTTCAACACGTTCATGATATGCCAGAGTCAGCAAAGAAGAAACAACTTATTAGACAGTTTAATAAGCAATCATTGACC
CAGACACCAGGGCGAGAACCTTCTACTTCCCAGGTACAAAAGAGGGCTCGTTCGCGCTCCTTCAGTGGGCTTATTAAGCGGAAGGTCCTGGGAAATCAGATGATGTCAGAAAAGAAAAAGAAGAACCC
TACTCCAGAATCTGTGGCCATTGGTGAATTGAAGGGAACCAGCAAAGAAAATAGGAACTTATTATTTTCTGGCTCTCCAGCTGTCACGATGACACCAACAAGATTGAAGTGGTCTGAAGGGAAGAAAG
AGGGGAAAAAAGGATTTCTCTGAAGGATCCAGAGTTGTCTCCTATGGTCCATGCAGAATTTTCTGTTTAGTGGGCAGGTGTTATTCCTGCCCACAGCAAAGCTTGGACTTGCAGCTTGCTTGCTGCAT
TTTGAATTGTCAAAGCCAACTAATACCGTGACCCGACTGATACCTCTAACCCCACTCACTGGATGATGTTTGCAAGCTGTGCCTTCTGAGAGAGTGCTTAGGCCCTGTCTCTCTTTTTTAATATTATG
GGGAAACCACTAACTATCCAACCAGCTTATACAGCACACTAAGGTGGGCTTCAGTGCTCACTCAATGTGTTTAGGCAGATTCCACTTTTGAAAAAAAATATGAAATGTGTGCTCAACTGCCAGTAATT
TTTTAAAAAGCACTGTCCCAGTGGATTGATGTTGTTTTTAATGGATATTTTGGGTTTTTCTCTGTTTTGATAGTATTGGGTATTTGGTTGTTTTTGTTTGTTTATTTCTTTGTTTTAAAAGCCATGTT
TTTGGTTGGGCTCTAAGCTAGATATCTTTCCCTCTTTTTCACTTTGAGCTTTGGGAAAACTCTTTATCTTATGAGGCTGTATTCCTCAATACCTAATTTGTGTCCAAAGAATTTATAGCTTTTCTGGA
CATTTTTTATTATTTCTTGGGTGTGACATCAGAGTATTTGACCTGCAGTATTGAAAAAGGAGAATTCAGAATGATACAGTATTTTAACAAATCTTAATTATTAAACTCTTTTCCTTCCTTCCATTTCT
CCCTCCCTTGTCCATCTCTCTCTCTCTTTCCCTTTCCTCAGTGATGTGAAAATAATTGTGTTTTGCTGAACTTGTTATCTTCATTCAATTTCCTCTTGACTAAAACATCTCTGGTGCCAACGTAATAC
TTCTGAACCAAATCACTGTGACTCAAGGAAAGTCACTGACAGCATAAGAGAAGTTTGCTAAAATATTTGTATGTGGGGGAAGCTCTGGAGTGTGCCTAGGAGGGGGCTGGCTGCCTTTATGTCCCAGG
ATGACTCTTTATGGGTGGGATTACATTGCACCCTCTGAGGGTGCAGGCTAGACCGTCTCCTGAGAGGAAGTTAGGATCAGAAAGAAGAAGCAAGCAGCAACCTCTGCAGGGCTGACAGGATTTAAAGG
AGAGAATGTTCTTATTTGGAAGCAGCTGTGGCTTGTCACCAATGTTCAAGGAGTGTTACTGTTCCGCCCTCTCTTTGTCAGAAGGGACACAGGTGGTAATTTGGAGATGGGGCCAGAGCTTCTGGCTT
TTGGATTTGGTGTGTTCACTTGTGTTGGATAGAGCAGTGGCATGGCTTTGACCTAGTATGAACTGGTGTCTGCCCAGAGAGCAGCATGTAGCAGGGGGGAATGCTCAGGTTTGTGCCTGGCTCTGTGG
AGCTGTACAACCCTTCTCACCCTGTGGGTTGGAGCCGAGTCAGGCCACTATGGGGAAGCAGTTGCCCCACAAAATGTGGTTTGCTGACCTATTTCTAAACTGTTGAATATGCTGCACCATTGCTGAAA
TGAAAGATGACTCTGGGGGAGCAGAGCTTGGCCTTGTGCCCAGCTGGCAGCCCCCTCTGCCAGCCTTTCTGCTGCTTTTGCTGCTGTAACAGCAATAGTGGAGAAAAATGTAAAATTTGGTCTTCCAG
CTTAATGCAGTGTGAACAATAGATGGTTAGGAAAACAAAACTGCTTAGAAGCCCCTTTCTCTAGAGCAGTTTTATGTCATTTGTAAAAACACATATTAGCAAATTCGTTTGCGTAGGTTTCTATTAAA
TATTTGACTTTTTTTTTCTTATTAAGAAAATGAAATCCCTTACACCAGATATCAGTTAATTCAAACAGAAAACCCTTTGGGTATCACCAAATTGAAATGGTATTCTTCCTTAACTCTTCCTTCTTTCC
TTTATTTGTTTAGACGTGCTTCATCCCGAAGTGGTGCTATGGTCTGTTAAACAGGGCTGGCATCAGGTAGAGGGAGCAGAGTGGTGACCTGATAGCTCCTGTCATCGTGTTAGTTTTTGATTCTATTT
AAGGGAAGTAGCTGAGATTTAGACGGATGTAGATGCTCTTTGGGTGAATGGAATCATAAGCAAAGGTTGTGTTCTGGGGTGAGGATCATGAGAGAGATATTTATCACATGCACATGCCTTTATATAGC
TGGTCTCCTTGGGTGGTTTATGTGTGTTTTGTTTATTTATTGAATATGTTTTCCCTTGCTTTAGGGGTTTTATAGGTCATTTTTCTTAATAGAAGCTGTGATCGACTTAGAATCCAAATTTGAGGAGT
AAGCAGCATAACCTTCTACCTTGTAATATGTAACTATTCTAATCCAGTGGAATCTTACGGAAAACACAGAGAAAACCCCTTTTATCATTTGCCACAGAAGGCTGCTGTCTCCCTTCTGATTTGGTGGG
CAGGTATTGTTTTTGAGCCAGTATTTAACAGAGTTTTTTAATCTATAAGATTTTTTTTGAATCTATTTCATTGTGTTTGTTTTTCATGTTGGAACAATCTCTCTGGAAGTGCCTCTTCTTGTGGCTTT
TACAACTTCATTTCTTTCTGGGGTCACCTGTGATGGGCTTTGATGTGGTGTCAATTTGGGGCCTTGTGTTTGTGCCAGAGGGATACACATATTAAACTGCAGGCCACCTTCCTGGTCCAGACTGTACT
GTGTGAACCCCACTGACTAAATTAGTGAGAACCATAGGCGTTGGAATTTCTCACCTTTTACAATGATAGACTTTTGCATTGGGACCAATGAATCTGGTGTGAAAAACCCTGCTGTAGTAGTGAAAGAG
CATCAGGAGATACTGACTGTACCTGAGGGCCAAAACAGGAGCAGGTAACGAACCGTAAAAAAAGGAGCAGGTAATGAATCGTAACCAAAACTACAGTTGATCCTCCGCAAAGGAAAGCTCTTTACCCA
GAATGTCCTTCCAGAGTCATTCAGGAAGGACAAGGGAACACCCTTGGGAAATGGGCTAGTGGAGGGCTGTTGACTGCAGTGACACCTGGGTGCTCCGGAGGTATCTGTTCTGTTGACCTGTAAGGAAG
CAGTCGATCCTAGAGTGTCAGAACAGAGCCATTCTCTCCTCCTGAGTAGGAACGTTTCTGTTCAGTTTCCCTCACAGCAGCCTGTGTTAGCATGCAGTTGAAAATACTGCCGTCTAGGAGAACCTGTG
GTCACTGGGAACGTGCCCCACAGTGACTGGCCATGCAACCAGGTGATTTTTAGGAATAGATGTCTCTAGACTCTGTCTCCTTTCCTACAAGGCCTCACACAGATGCTTGAGGCTAATGGCCCCCATTC
TGAGGTCATTTTTGTGTAGAACTCCTTTCCCCAGGAGAGAGCCTTATCTCTGCCCTCCTTTACCCTGAAGGCTTCAAACGGAAGACAGGACCTAGATCTAAACCTAGATACTAGCATTTTGTGGGATT
GTCTAGAATTTGGGGAAGATTTGGGTTCCTAAGATGCACAAGCGTTTTACACCAGTGGTGATTAACTCAACTAAAACCCACTGTAGGAAGTTAGCTTCCCCAGACAGCTAATGCCGAGATCTTCTACC
AGCGTAGAGTTGACAGAAGCAGGCCAGCGAGGAGGTGTGGGACATAATAGCCTGAGTGCTTGGGTTACCATGGAGACTGGAGTGTGTGAGGCCACAGCCTGTGCTAAAGAGCCATGGAGCCCTCCCCT
GGCCATGTCTGGGGACAGATAGAACCTGTTGGGGGAAATATTCCCTCACCCCAGGGTTCTTTCTGCAGAGCAAGGGTTGCCTTTGTCCTATCCCTGAGCTTGCTCAACAAGAGAAACAAGGTTTCTTA
AGTGTTTTGGTTAAAGTTTTCATTCTTATTTGACTATGTATATGTAATTGTAAAGAAACGATCCTATGCATTGTCTTTCTTTTATATTCTTGTAATATTCTGAAATTAAAATTGTTTTGTTTCATA

hide sequence


Protein RefSeqs	NP_001191229	(Get FASTA)	NCBI Sequence Viewer
	NP_001243352	(Get FASTA)	NCBI Sequence Viewer
	NP_116289	(Get FASTA)	NCBI Sequence Viewer
GenBank Protein	AAI13889	(Get FASTA)	NCBI Sequence Viewer
	AAI14491	(Get FASTA)	NCBI Sequence Viewer
	ABC69298	(Get FASTA)	NCBI Sequence Viewer
	BAB84948	(Get FASTA)	NCBI Sequence Viewer
	BAC03428	(Get FASTA)	NCBI Sequence Viewer
	BAC04130	(Get FASTA)	NCBI Sequence Viewer
	BAC04165	(Get FASTA)	NCBI Sequence Viewer
	BAG64173	(Get FASTA)	NCBI Sequence Viewer
	CAH18254	(Get FASTA)	NCBI Sequence Viewer
	EAW49952	(Get FASTA)	NCBI Sequence Viewer
	EAW49953	(Get FASTA)	NCBI Sequence Viewer
	EAW49954	(Get FASTA)	NCBI Sequence Viewer
	EAW49955	(Get FASTA)	NCBI Sequence Viewer
Ensembl Protein	ENSP00000351058
	ENSP00000351058.4
	ENSP00000351333
	ENSP00000351333.4
	ENSP00000360066
	ENSP00000360066.1
GenBank Protein	Q14CB8	(Get FASTA)	NCBI Sequence Viewer
	SPT35690	(Get FASTA)	NCBI Sequence Viewer

RefSeq Acc Id:	NP_116289 ⟸ NM_032900
- Peptide Label:	isoform 1
- UniProtKB:	Q8NF34 (UniProtKB/Swiss-Prot), Q8N9X1 (UniProtKB/Swiss-Prot), Q68DG6 (UniProtKB/Swiss-Prot), Q5T462 (UniProtKB/Swiss-Prot), Q5T460 (UniProtKB/Swiss-Prot), Q5J8M2 (UniProtKB/Swiss-Prot), Q14CF2 (UniProtKB/Swiss-Prot), B4DZR1 (UniProtKB/Swiss-Prot), A1XCP1 (UniProtKB/Swiss-Prot), Q8TEK1 (UniProtKB/Swiss-Prot), Q14CB8 (UniProtKB/Swiss-Prot), A0A2X0U4I8 (UniProtKB/TrEMBL)
- Sequence:	show sequence MATEAQSEGEVPARESGRSDAICSFVICNDSSLRGQPIIFNPDFFVEKLRHEKPEIFTELVVSNITRLIDLPGTELAQLMGEVDLKLPGGAGPASGFFRSLMSLKRKEKGVIFGSPLTEEGIAQIYQL IEYLHKNLRVEGLFRVPGNSVRQQILRDALNNGTDIDLESGEFHSNDVATLLKMFLGELPEPLLTHKHFNAHLKIADLMQFDDKGNKTNIPDKDRQIEALQLLFLILPPPNRNLLKLLLDLLYQTAKK QDKNKMSAYNLALMFAPHVLWPKNVTANDLQENITKLNSGMAFMIKHSQKLFKAPAYIRECARLHYLGSRTQASKDDLDLIASCHTKSFQLAKSQKRNRVDSCPHQEETQHHTEEALRELFQHVHDMP ESAKKKQLIRQFNKQSLTQTPGREPSTSQVQKRARSRSFSGLIKRKVLGNQMMSEKKKKNPTPESVAIGELKGTSKENRNLLFSGSPAVTMTPTRLKWSEGKKEGKKGFL hide sequence

RefSeq Acc Id:	NP_001191229 ⟸ NM_001204300
- Peptide Label:	isoform 2
- UniProtKB:	A0A2X0U4I8 (UniProtKB/TrEMBL)
- Sequence:	show sequence MATEAQSEGEVPARESGRSDAICSFVICNDSSLRGQPIIFNPDFFVEKLRHEKPEIFTELVVSNITRLIDLPGTELAQLMGEVDLKLPGGAGPASGFFRSLMSLKRKEKGVIFGSPLTEEGIAQIYQL IEYLHKNLRVEGLFRVPGNSVRQQILRDALNNGTDIDLESGEFHSNDVATLLKMFLGELPEPLLTHKHFNAHLKIADLMQFDDKGNKTNIPDKDRQIEALQLLFLILPPPNRNLLKLLLDLLYQTAKK QDKNKMSAYNLALMFAPHVLWPKNAPAYIRECARLHYLGSRTQASKDDLDLIASCHTKSFQLAKSQKRNRVDSCPHQEETQHHTEEALRELFQHVHDMPESAKKKQLIRQFNKQSLTQTPGREPSTSQ VQKRARSRSFSGLIKRKVLGNQMMSEKKKKNPTPESVAIGELKGTSKENRNLLFSGSPAVTMTPTRLKWSEGKKEGKKGFL hide sequence

RefSeq Acc Id:	NP_001243352 ⟸ NM_001256423
- Peptide Label:	isoform 3
- UniProtKB:	A0A2X0U4I8 (UniProtKB/TrEMBL)
- Sequence:	show sequence MPHQKLSALIDAICSFVICNDSSLRGQPIIFNPDFFVEKLRHEKPEIFTELVVSNITRLIDLPGTELAQLMGEVDLKLPGGAGPASGFFRSLMSLKRKEKGVIFGSPLTEEGIAQIYQLIEYLHKNLR VEGLFRVPGNSVRQQILRDALNNGTDIDLESGEFHSNDVATLLKMFLGELPEPLLTHKHFNAHLKIADLMQFDDKGNKTNIPDKDRQIEALQLLFLILPPPNRNLLKLLLDLLYQTAKKQDKNKMSAY NLALMFAPHVLWPKNVTANDLQENITKLNSGMAFMIKHSQKLFKAPAYIRECARLHYLGSRTQASKDDLDLIASCHTKSFQLAKSQKRNRVDSCPHQEETQHHTEEALRELFQHVHDMPESAKKKQLI RQFNKQSLTQTPGREPSTSQVQKRARSRSFSGLIKRKVLGNQMMSEKKKKNPTPESVAIGELKGTSKENRNLLFSGSPAVTMTPTRLKWSEGKKEGKKGFL hide sequence

Ensembl Acc Id:

ENSP00000360066 ⟸ ENST00000371027

Ensembl Acc Id:

ENSP00000473667 ⟸ ENST00000466484

Protein Domains

Rho-GAP

Name	Modeler	Protein Id	AA Range	Protein Structure
AF-Q14CB8-F1-model_v2	AlphaFold	Q14CB8	1-494	view protein structure

RGD ID:

7218305

Promoter ID:

EPDNEW_H14898

Type:

initiation region

Name:

ARHGAP19_3

Description:

Rho GTPase activating protein 19

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H14899 EPDNEW_H14900 EPDNEW_H14901

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,222,398 - 97,222,458	EPDNEW

RGD ID:

7218307

Promoter ID:

EPDNEW_H14899

Type:

initiation region

Name:

ARHGAP19_2

Description:

Rho GTPase activating protein 19

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H14898 EPDNEW_H14900 EPDNEW_H14901

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,265,937 - 97,265,997	EPDNEW

RGD ID:

7218309

Promoter ID:

EPDNEW_H14900

Type:

initiation region

Name:

ARHGAP19_4

Description:

Rho GTPase activating protein 19

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H14898 EPDNEW_H14899 EPDNEW_H14901

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,270,657 - 97,270,717	EPDNEW

RGD ID:

7218311

Promoter ID:

EPDNEW_H14901

Type:

initiation region

Name:

ARHGAP19_1

Description:

Rho GTPase activating protein 19

SO ACC ID:

SO:0000170

Source:

EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)

Alternative Promoters:

null; see alsoEPDNEW_H14898 EPDNEW_H14899 EPDNEW_H14900

Experiment Methods:

Single-end sequencing.; Paired-end sequencing.

Position:

Human Assembly	Chr	Position (strand)	Source
GRCh38	10	97,292,637 - 97,292,697	EPDNEW

RGD ID:

6814944

Promoter ID:

HG_MRA:2148

Type:

Non-CpG

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

K562

Transcripts:

U79256

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	10	98,972,051 - 98,972,551 (-)	MPROMDB

RGD ID:

6787367

Promoter ID:

HG_KWN:10736

Type:

CpG-Island

SO ACC ID:

SO:0000170

Source:

MPROMDB

Tissues & Cell Lines:

CD4+TCell, CD4+TCell_12Hour, CD4+TCell_2Hour, HeLa_S3, Jurkat, K562, Lymphoblastoid, NB4

Transcripts:

ENST00000316676, ENST00000358308, ENST00000393817, NM_032900, OTTHUMT00000049650, UC001KMY.2, UC009XVI.1, UC009XVJ.1, UC009XVK.1

Position:

Human Assembly	Chr	Position (strand)	Source
Build 36	10	99,042,061 - 99,042,561 (-)	MPROMDB

Database	Acc Id	Source(s)
COSMIC	ARHGAP19	COSMIC
Ensembl Genes	ENSG00000213390	Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot
Ensembl Transcript	ENST00000358308	ENTREZGENE
	ENST00000358308.7	UniProtKB/Swiss-Prot
	ENST00000358531	ENTREZGENE
	ENST00000358531.9	UniProtKB/Swiss-Prot
	ENST00000371027	ENTREZGENE
	ENST00000371027.5	UniProtKB/Swiss-Prot
Gene3D-CATH	1.10.555.10	UniProtKB/Swiss-Prot
GTEx	ENSG00000213390	GTEx
HGNC ID	HGNC:23724	ENTREZGENE
Human Proteome Map	ARHGAP19	Human Proteome Map
InterPro	ARHGAP19_RhoGAP	UniProtKB/Swiss-Prot
	Rho_GTPase_activation_prot	UniProtKB/Swiss-Prot
	RhoGAP_dom	UniProtKB/Swiss-Prot
KEGG Report	hsa:84986	UniProtKB/Swiss-Prot
NCBI Gene	84986	ENTREZGENE
OMIM	611587	OMIM
PANTHER	RHO GTPASE ACTIVATING PROTEIN 18,19-RELATED	UniProtKB/Swiss-Prot
	RHO GTPASE-ACTIVATING PROTEIN 19	UniProtKB/Swiss-Prot
Pfam	RhoGAP	UniProtKB/Swiss-Prot
PharmGKB	PA134917415	PharmGKB
PROSITE	RHOGAP	UniProtKB/Swiss-Prot
SMART	RhoGAP	UniProtKB/Swiss-Prot
Superfamily-SCOP	SSF48350	UniProtKB/Swiss-Prot
UniProt	A0A2X0U4I8	ENTREZGENE, UniProtKB/TrEMBL
	A1XCP1	ENTREZGENE
	B4DZR1	ENTREZGENE
	Q14CB8	ENTREZGENE
	Q14CF2	ENTREZGENE
	Q5J8M2	ENTREZGENE
	Q5T460	ENTREZGENE
	Q5T462	ENTREZGENE
	Q68DG6	ENTREZGENE
	Q8N9X1	ENTREZGENE
	Q8NF34	ENTREZGENE
	Q8TEK1	ENTREZGENE
	R4GMS4_HUMAN	UniProtKB/TrEMBL
	R4GNI4_HUMAN	UniProtKB/TrEMBL
	RHG19_HUMAN	UniProtKB/Swiss-Prot
UniProt Secondary	A1XCP1	UniProtKB/Swiss-Prot
	B4DZR1	UniProtKB/Swiss-Prot
	Q14CF2	UniProtKB/Swiss-Prot
	Q5J8M2	UniProtKB/Swiss-Prot
	Q5T460	UniProtKB/Swiss-Prot
	Q5T462	UniProtKB/Swiss-Prot
	Q68DG6	UniProtKB/Swiss-Prot
	Q8N9X1	UniProtKB/Swiss-Prot
	Q8NF34	UniProtKB/Swiss-Prot
	Q8TEK1	UniProtKB/Swiss-Prot

Gene Annotator (Functional Annotation) unavailable	Gene Annotator (Annotation Distribution) unavailable	Variant Visualizer (Genomic Variants) unavailable


InterViewer (Protein-Protein Interactions) unavailable	Gviewer (Genome Viewer) unavailable	Variant Visualizer (Damaging Variants) unavailable


Gene Annotator (Annotation Comparison) unavailable	OLGA (Gene List Generator) unavailable
		Excel (Download)

MOET (Multi-Ontology Enrichement) unavailable	GOLF (Gene-Ortholog Location Finder) unavailable

Send us a Message